Publications by authors named "Gerald J Duke"

Claim this Profile
S
Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO).
Carol H Hu, Meriah W Neissel Valente, O Scott Halpern, Sutjano Jusuf, Javed A Khan, Gerald J Duke

Bioorg Med Chem Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.
Franck Duclos, Lynn M Abell, David G Harden, Kristen Pike, Kimberly Nowak, Gerald J Duke

Medchemcomm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, functional and structural characterization of an inhibitor of N-acetylneuraminate-9-phosphate phosphatase: observation of extensive dynamics in an enzyme/inhibitor complex.
Soong-Hoon Kim, Keith L Constantine, Gerald J Duke, Valentina Goldfarb, John T Hunt

Bioorg Med Chem Lett· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.
John S Sack, Sandrine Thieffine, Tiziano Bandiera, Marina Fasolini, Gerald J Duke

Biochem J· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing compound binding to the Eg5 motor domain using a thermal shift assay.
Patricia A McDonnell, Joseph Yanchunas, John A Newitt, Li Tao, Susan E Kiefer, Gerald J Duke

Anal Biochem· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
John S Sack, Kevin F Kish, Matthew Pokross, Dianlin Xie, Gerald J Duke

Acta Crystallogr D Biol Crystallogr· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.
Stephen T Wrobleski, Shuqun Lin, John Hynes, Hong Wu, Sidney Pitt, Gerald J Duke

Bioorg Med Chem Lett· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis